(Q52188052)

26 April 2018

title

Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia. (English)

1 reference

26 April 2018

author

Gary Bellus

3

1 reference

26 April 2018

author name string

Hamosh A

1

1 reference

26 April 2018

Maher JF

2

1 reference

26 April 2018

Rasmussen SA

4

1 reference

26 April 2018

Johnston MV

5

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 April 1998

1 reference

26 April 2018

The Journal of Pediatrics

published in

1 reference

26 April 2018

volume

132

1 reference

26 April 2018

issue

4

1 reference

26 April 2018

page(s)

709-713

1 reference

26 April 2018

The glycine cleavage system: Composition, reaction mechanism, and physiological significance

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970365-8

Non-ketotic hyperglycinaemia: molecular lesion, diagnosis and pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970365-8

Physiological and pathophysiological roles of excitatory amino acids during central nervous system development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970365-8

Dextromethorphan inhibits NMDA-induced convulsions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970365-8

Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970365-8

Prenatal diagnosis of non-ketotic hyperglycinaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970365-8

Atypical nonketotic hyperglycinemia confirmed by assay of the glycine cleavage system in lymphoblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970365-8

Nonketotic hyperglycinemia: Treatment with NMDA antagonist and consideration of neuropathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970365-8

Nonketotic hyperglycinemia: clinical and electrophysiologic effects of dextromethorphan, an antagonist of the NMDA receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970365-8

Drug refractory epilepsy in brain damage: effect of dextromethorphan on EEG in four patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970365-8

Failure of early dextromethorphan and sodium benzoate therapy in an infant with nonketotic hyperglycinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970365-8

10.1016/S0022-3476(98)70365-8

7 January 2021

Identifiers

DOI

1 reference

26 April 2018

release_5npimq24zfgbzm74ftvjlo6yea

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5npimq24zfgbzm74ftvjlo6yea

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

26 April 2018